GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dong-E-E-Jiao Co 000423.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

50.40

-0.88%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Dong-E-E-Jiao Co

Its shares trade on Shenzhen under the ticker 000423.SZ. It has been listed since 29 July 1996. In the fiscal year to 31 December 2025, it reported revenue of CN¥6.64bn and net income of CN¥1.74bn. At that date it held total assets of CN¥13.38bn and shareholders' equity of CN¥10.34bn.

Dong-E-E-Jiao Co., Ltd. engages in the research and development, manufacturing and sale of proprietary Chinese medicine, health care products, and biological drugs. The company is headquartered in Liaocheng, Shandong. The firm distributes its Ejiao and Ejiao series products under the brand name of Dong-E E-Jiao. The firm is also involved in the production and sale of medical instrument and pharmaceutical excipients, as well as pharmaceutical trading business. The firm operates its business in domestic market, with East China and South China as its main markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
29 Jul 1996
Employees
4,180

Leadership

Pay as last reported

  • Mr. Jie ChengChairman of the Board, since 2022CN¥2.7m
  • Ms. Jinni SunPresident, Director, since 2024
  • Mr. Hongyan DingChief Financial Officer, Vice President, Secretary of the Board, Director, since 2023CN¥839,000
  • Mr. Qingchuan LiVice PresidentCN¥839,000
  • Mr. Xinhua LiVice PresidentCN¥1.5m
  • Mr. Guangyuan LiuVice PresidentCN¥1.9m
  • Mr. Xingpin CuiDirector
  • Ms. Xiaoyue WangDirector
  • Mr. Peiqing XuDirector
  • Mr. De'an GuoIndependent DirectorCN¥120,000
  • Mr. Xiaobo SunIndependent Director
  • Mr. Guangwei WenIndependent DirectorCN¥120,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
75
Environment
99
Social
81
Governance
45
Direct emissions (scope 1)
20,045.69 t
Energy emissions (scope 2)
21,643.96 t
Women in the workforce
47.30159%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Dong-E-E-Jiao Co Ltd possesses several key strengths that contribute to its success in the market. Firstly, the company benefits from a strong brand reputation built over many years of operation. This allows them to enjoy a loyal customer base and gain a competitive edge. Additionally, the company boasts a diversified product portfolio, offering a wide range of Dong-E-E-Jiao products that cater to various consumer needs. Lastly, the company prides itself on its extensive distribution network, enabling easy access to its products domestically and internationally.

Weaknesses

  • Despite its strengths, Dong-E-E-Jiao Co Ltd also faces certain weaknesses that should be considered. One notable weakness is its dependence on a single product line, namely Dong-E-E-Jiao. This poses a potential risk as any decline in demand for this product could significantly impact the company's revenue. Additionally, the company may face challenges in expanding its market share due to increasing competition from both domestic and international competitors.

Opportunities

  • Dong-E-E-Jiao Co Ltd operates in an industry with several opportunities for growth. Firstly, the growing consumer awareness and demand for traditional Chinese medicine and natural health products provide a favorable market environment for the company. By capitalizing on this trend, Dong-E-E-Jiao Co Ltd can potentially expand its customer base and increase sales. Furthermore, the company could explore opportunities for international expansion, tapping into new markets and diversifying its revenue sources.

Threats

  • Dong-E-E-Jiao Co Ltd must also be vigilant of the threats that may impact its business operations. One major threat is the potential impact of government regulations and policies on the traditional medicine industry. Changes in regulations could affect the production, marketing, and distribution of Dong-E-E-Jiao products. Additionally, the company must remain aware of the evolving consumer preferences and changing market dynamics to stay competitive and avoid losing market share to rivals.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.